The protein–protein complex formed between the kinase Aurora-A and the oncogenic transcription factor MYCN antagonizes proteasomal degradation of MYCN in neuroblastoma cells (Otto et al., 2009 ▸). Here, MYCN is linked to neuroblastoma.